A study of chemoembolization with irinotecan-eluting beads in treatment of metastatic CRC demonstrated a 50–90% reduction of tumor marker carcinoembryonic antigen (CEA), significant reduction of contrast enhancement on postprocedure CT imaging, and downstaging of CRC metastases [6]. The gene discussed is CEACAM5; the disease is neoplasm.